Clinical Trials Directory

Trials / Unknown

UnknownNCT01956201

Efficacy and Safety of Fenofibrate Added on to Atorvastatin Compared With Atorvastatin

Efficacy and Safety of Fenofibrate Added on to Atorvastatin Compared With Atorvastatin in Mixed Hypercholesterolemic Patient: Multi Center, Randomized, Double-blind, Parallel-group, Therapeutic Confirmatory Study.

Status
Unknown
Phase
Phase 3
Study type
Interventional
Enrollment
476 (estimated)
Sponsor
Chong Kun Dang Pharmaceutical · Industry
Sex
All
Age
19 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the efficacy and safety of Atorvastatin and Fenofibrate compared with atorvastatin monotherapy in mixed hypercholesterolemic patients.

Detailed description

Multi center, randomized, double-blind, parallel-group, therapeutic confirmatory study Primary Outcome Measure: The mean percent change of Non-HDL Cholesterol \[Time Frame: from baseline at week 8\] Secondary Outcome Measures: The achievement rate of LDL-C\<100mg/dl, Non-HDL-C\<130mg/dl \[Time Frame: from baseline at week 8\] The mean percent change of LDL-C, HDL-C, TG, TC, Apo-AI, Apo-B \[Time Frame: from baseline at week 4, 8\] The mean percent change of Non-LDL-C/HDL-C, TC/HDL-C, LDL-C/HDL-C, Apo-B/Apo-AI \[Time Frame: from baseline at week 4, 8\] The mean percent change of Fibrinogen, hs-CRP \[Time Frame: from baseline at week 4, 8\] Safety evaluation \[Time Frame: Treatment period and Extension period\]

Conditions

Interventions

TypeNameDescription
DRUGAtorvastatin 20mg\[Atorvastatin Run-in Period\] Take Atorvastatin 20mg 1 tablet once a day (after breakfast) \[Treatment Period\] Take Atrovastatin 20mg/Fenofibrate 160mg or Atorvastiatin 20mg/Placebo of Finofibrate 160mg 2 tablet once a day (after breakfast) \[Extension Period\] Take Atrovastatin 20mg, Fenofibrate 160mg 2 tablet once a day (after breakfast)
DRUGFenofibrate 160mgRefer to Intervention Description of Atorvastatin 20mg
OTHERPlacebo (Fenofibrate 160 mg)Refer to Intervention Description of Atorvastatin 20mg

Timeline

Start date
2013-12-01
Primary completion
2016-08-01
Completion
2016-08-01
First posted
2013-10-08
Last updated
2015-02-04

Locations

30 sites across 1 country: South Korea

Source: ClinicalTrials.gov record NCT01956201. Inclusion in this directory is not an endorsement.